Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04776837

Predicting Disease Progression and/or Recurrence in Cancer

Sponsor: Massachusetts General Hospital

View on ClinicalTrials.gov

Summary

This is a prospective study addressing the challenge of predicting disease progression and/or recurrence in patients diagnosed with metastatic colorectal, pancreatobiliary, or esophagogastric cancer that are receiving anti-cancer therapy.

Official title: Tumor Markers, Liquid Biopsies, and Patient Reported Outcomes in Metastatic Colorectal, Pancreas, Biliary, and Esophagogastric Cancers

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

159

Start Date

2019-05-15

Completion Date

2022-10-19

Last Updated

2026-05-15

Healthy Volunteers

No

Interventions

BEHAVIORAL

Observational Cohort

Patients will be followed by collecting clinical data, biospecimens, and quality of life assessment

Locations (1)

Massachusetts General Hospital

Boston, Massachusetts, United States